A strong Clinical Quality Assurance (CQA) framework is essential for maintaining the integrity, reliability, and compliance of clinical programs. Our CQA services provide proactive to reactive quality support to sponsors and CROs, ensuring adherence to regulatory standards and industry best practices. Ensure Clinical Quality & Compliance with Expert Support.
Oversight and compliance support for CROs, investigator sites, central labs, pharmacies, animal/toxicology studies, SaaS providers, and other vendors to ensure regulatory adherence and performance.
Identifying and resolving clinical trial issues to mitigate risks and improve study outcomes.
Thorough assessments of Trial Master Files to ensure completeness, accuracy, and regulatory compliance.
Tailored support to address specific clinical quality challenges and operational needs.
A structured auditing approach is essential for identifying compliance gaps, mitigating risks, and ensuring regulatory readiness. Our clinical auditing services help organizations maintain compliance with global regulatory expectations.
Regulatory inspections can be complex and high-stakes. Our inspection readiness services ensure your organization is fully prepared to meet global regulatory expectations with confidence.
Evaluating your current QMS and scaling solutions to fit your organization’s size, scope, and regulatory requirements.
Creating and refining policies, SOPs, and quality documents to ensure compliance with industry standards.
Supporting the seamless integration of quality management systems across your operations.
Providing in-depth training on QMS best practices, regulatory expectations, and continuous improvement strategies.
Whether you're building a new QMS or enhancing an existing system, our experts provide tailored solutions to ensure compliance and efficiency.
At ProPharma, we provide expert clinical consulting services to medical device and diagnostics companies. Helping to navigate and ensure compliance to complex global regulatory requirements while achieving operational excellence.
Our team specializes in supporting the unique requirements of medical device companies in meeting international compliance standards, including:
July 23, 2026
The FDA's transition to the QMSR simplifies compliance, emphasizing risk management and aligning with global standards for medical devices compared to QMR.
July 20, 2026
Discover effective strategies for building relationships with clinical trial sites to streamline the study start-up process and enhance activation timelines.
July 17, 2026
FDA is reviewing seven popular peptides for potential inclusion on the 503A Bulks List. Learn what the review means for compounding pharmacies and patient access.
July 8, 2026
ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.
June 18, 2026
ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.
May 27, 2026
ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.
.png?width=320&height=185&name=6%20-%20Medical%20Information%20%20(650%20x%20425%20px).png)
.png?width=320&height=185&name=4%20-%20Quality%20%26%20Compliance%20(650%20x%20425%20px).png)
.png?width=320&height=185&name=Webinar%20Thumbnail%20Quality%20%26%20Compliance%20(650%20x%20425%20px).png)